Microbot Medical (MBOT) Net Equity Issued and Repurchased (2010 - 2025)

Microbot Medical (MBOT) has 12 years of Net Equity Issued and Repurchased data on file, last reported at $4.8 million in Q2 2025.

• Quarterly Net Equity Issued and Repurchased rose 58.4% year-over-year to $4.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $48.6 million (up 1518.6% YoY) and the FY2025 annual result came in at $86.2 million, up 986.68% from the prior year.
• Net Equity Issued and Repurchased slipped to $4.8 million in Q2 2025, from $27.8 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $27.8 million in Q1 2025 to a low of -$161000.0 in Q3 2023.
• A 3-year average of $7.7 million and a median of $4.8 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased surged 3826.71% — and 2025, when it soared 58.4%.
• Tracing MBOT's Net Equity Issued and Repurchased over 3 years: stood at -$161000.0 in 2023, then jumped by 6311.18% to $10.0 million in 2024, then sank by 52.48% to $4.8 million in 2025.
• The last three Net Equity Issued and Repurchased figures came in at $4.8 million (Q2 2025), $27.8 million (Q1 2025), and $10.0 million (Q4 2024), per Business Quant data.